AU617318B2 - Outer membrane protein f of pseudomonas aeruginosa - Google Patents
Outer membrane protein f of pseudomonas aeruginosaInfo
- Publication number
- AU617318B2 AU617318B2 AU16977/88A AU1697788A AU617318B2 AU 617318 B2 AU617318 B2 AU 617318B2 AU 16977/88 A AU16977/88 A AU 16977/88A AU 1697788 A AU1697788 A AU 1697788A AU 617318 B2 AU617318 B2 AU 617318B2
- Authority
- AU
- Australia
- Prior art keywords
- pseudomonas aeruginosa
- membrane protein
- outer membrane
- ompf
- vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 101710203389 Outer membrane porin F Proteins 0.000 title abstract 4
- 101710160104 Outer membrane protein F Proteins 0.000 title abstract 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
Abstract
The gene for outer membrane protein F (OMPF) of Pseudomonas aeruginosa has been isolated, sequenced and expressed to produce OMPF and immunogenic part-sequences in the amount and purity necessary for use for the preparation of vaccines.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873718591 DE3718591A1 (en) | 1987-06-03 | 1987-06-03 | AEUSSERES MEMBRANE PROTEIN F BY PSEUDOMONAS AERUGINOSA |
DE3718591 | 1987-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1697788A AU1697788A (en) | 1988-12-08 |
AU617318B2 true AU617318B2 (en) | 1991-11-28 |
Family
ID=6328966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU16977/88A Ceased AU617318B2 (en) | 1987-06-03 | 1988-06-02 | Outer membrane protein f of pseudomonas aeruginosa |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0297291B1 (en) |
JP (5) | JPS6485086A (en) |
AT (1) | ATE95564T1 (en) |
AU (1) | AU617318B2 (en) |
CA (1) | CA1341015C (en) |
DE (2) | DE3718591A1 (en) |
ES (1) | ES2059436T3 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8900670A (en) * | 1989-03-17 | 1990-10-16 | Stichting Tech Wetenschapp | POLYNUCLEOTIDE PROBE, METHOD AND KIT FOR IDENTIFYING AND DETECTING GRAM-NEGATIVE BACTERIA. |
WO1993024636A1 (en) * | 1992-05-29 | 1993-12-09 | The University Of British Columbia | Use of protein oprf for bacterial cell surface expression of oligopeptides |
US20020055101A1 (en) | 1995-09-11 | 2002-05-09 | Michel G. Bergeron | Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
US6001564A (en) * | 1994-09-12 | 1999-12-14 | Infectio Diagnostic, Inc. | Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
DE69515613T2 (en) | 1994-12-16 | 2000-11-30 | Chiron Behring Gmbh & Co. | Immunogenic hybrid protein OprF-Oprl available from membrane proteins from Pseudomonas aeruginosa |
US5994066A (en) * | 1995-09-11 | 1999-11-30 | Infectio Diagnostic, Inc. | Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
US20030049636A1 (en) | 1999-05-03 | 2003-03-13 | Bergeron Michel G. | Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
US20100267012A1 (en) | 1997-11-04 | 2010-10-21 | Bergeron Michel G | Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
KR100461710B1 (en) * | 1997-09-13 | 2005-09-28 | 씨제이 주식회사 | Novel Pseudomonas aeruginosa cell membrane protein gene and vaccine for preventing Pseudomonas aeruginosa infection using the same |
GB9915044D0 (en) * | 1999-06-25 | 1999-08-25 | Smithkline Beecham Biolog | Novel compounds |
JP2003511015A (en) | 1999-09-28 | 2003-03-25 | インフェクティオ ダイアグノスティク(アイ.ディー.アイ.)インコーポレイティド | Generating highly conserved genes, as well as species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers, algae, archaea, bacteria, fungi from diagnostic clinical specimens And their use for rapid detection and identification of parasite microorganisms |
EP1790659B1 (en) | 2001-11-13 | 2013-07-31 | ID Biomedical Corporation | Polypeptides of pseudomonas aeruginosa |
EP1458752A2 (en) | 2001-11-13 | 2004-09-22 | Shire Biochem Inc. | Polypeptides of pseudomonas aeruginosa |
EP3345617B1 (en) | 2012-11-30 | 2020-08-26 | GlaxoSmithKline Biologicals S.A. | Pseudomonas antigens and antigen combinations |
WO2017005670A1 (en) | 2015-07-04 | 2017-01-12 | Evaxion Biotech Aps | Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa |
WO2018127545A1 (en) | 2017-01-05 | 2018-07-12 | Evaxion Biotech Aps | Vaccines targeting pseudomonas aeruginosa |
-
1987
- 1987-06-03 DE DE19873718591 patent/DE3718591A1/en not_active Withdrawn
-
1988
- 1988-05-30 EP EP88108609A patent/EP0297291B1/en not_active Expired - Lifetime
- 1988-05-30 DE DE88108609T patent/DE3884680D1/en not_active Expired - Lifetime
- 1988-05-30 AT AT88108609T patent/ATE95564T1/en not_active IP Right Cessation
- 1988-05-30 ES ES88108609T patent/ES2059436T3/en not_active Expired - Lifetime
- 1988-06-02 AU AU16977/88A patent/AU617318B2/en not_active Ceased
- 1988-06-02 CA CA000568463A patent/CA1341015C/en not_active Expired - Fee Related
- 1988-06-03 JP JP63137206A patent/JPS6485086A/en active Pending
-
1998
- 1998-09-14 JP JP10260701A patent/JP2000074922A/en active Pending
-
2001
- 2001-11-28 JP JP2001363345A patent/JP2002165593A/en not_active Withdrawn
-
2003
- 2003-04-07 JP JP2003103084A patent/JP2003289889A/en not_active Withdrawn
-
2005
- 2005-12-27 JP JP2005376657A patent/JP2006187286A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0297291A3 (en) | 1989-03-29 |
DE3718591A1 (en) | 1988-12-15 |
ES2059436T3 (en) | 1994-11-16 |
DE3884680D1 (en) | 1993-11-11 |
EP0297291A2 (en) | 1989-01-04 |
JP2006187286A (en) | 2006-07-20 |
AU1697788A (en) | 1988-12-08 |
JP2003289889A (en) | 2003-10-14 |
ATE95564T1 (en) | 1993-10-15 |
JP2002165593A (en) | 2002-06-11 |
JPS6485086A (en) | 1989-03-30 |
EP0297291B1 (en) | 1993-10-06 |
CA1341015C (en) | 2000-06-06 |
JP2000074922A (en) | 2000-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU617318B2 (en) | Outer membrane protein f of pseudomonas aeruginosa | |
EP0217580A3 (en) | Therapeutic nucleosides | |
AU567257B2 (en) | Sucralfat-suspension | |
EP1013284A3 (en) | Purified forms of dnase | |
AU1170588A (en) | Methods and deoxyribonucleic acid for the preparation of tissue factor protein | |
HK14294A (en) | Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid | |
AU5612686A (en) | Aids antigen, diagnosis and immunogenic compositions | |
AU7073087A (en) | Thiolactam-N-acetic acid derivatives, their production and use | |
EP0306219A3 (en) | Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids | |
WO1996034964A3 (en) | Stable variant hk2 polypeptide | |
AU5185886A (en) | Stable dispersions of polyureas and/or polyhydrazodi- carbonamides in relatively high molecular weight, hydroxyl group containing compounds, process for the production thereof and use thereof for the production of polyurethanes | |
EP0338410A3 (en) | Escherichia coli secretor mutants | |
WO1991015512A3 (en) | Hiv envelope polypeptides | |
IL91184A0 (en) | N-2,3-butadienyl tri-and tetraaminoalkane derivatives | |
AU1907992A (en) | Pharmaceutical enema preparation | |
MY103362A (en) | Production of proteins in active forms | |
ES2004099A6 (en) | Use of biologically active polypeptides and compositions containing them. | |
AU2458988A (en) | The preparation, by genetic manipulation, of anticoagulative protein pp4 | |
AU536582B2 (en) | Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends | |
AU4016089A (en) | The expression of homologous and heterologous proteins, which are able to function, on the outer membrane of e. coli and other gram-negative bacteria | |
AU1887988A (en) | Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use | |
WO1987001698A3 (en) | 1,4-naphthalenediol and 1,4-hydroquinone derivatives | |
DE3279949D1 (en) | Novel microorganisms of the genus eschericia, hybrid dna for use in their production and the use of the microorganisms in the preparation of glutathione | |
AU7633987A (en) | The use of 15-deoxyspergualine as a pharmaceutical | |
AU1321988A (en) | The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein |